clairop

Why Junk Food Feels Better With Crohn's

Chips and white bread sit better than salad and steak because healthy and easy to digest are different properties. The measured mechanisms, and what they mean.

Clairop Team44 min read

Photo: bahareh moradian / Unsplash

The short answer

Whole plant foods ask your gut to do mechanical and fermentative work that refined, soft food does not. Particle size, fructan load, fat-driven transit slowing and your own fermentation capacity are the measured mechanisms. A 1985 trial found a low residue diet changed no outcome in non-stenosing Crohn's, and the largest prospective flare study found no consistent ultra-processed food link.

If a quarter pounder and fries go down without incident and a home-cooked stir fry leaves you doubled over, you are not broken and you are not imagining it. "Healthy" and "easy to digest" are different properties of food, and they frequently point in opposite directions. The foods with the most nutrients per bite are also the foods that arrive in your intestine with the most intact structure and the most fermentable carbohydrate, and a gut with Crohn's disease is worse than average at handling both of those things.

This article is about the mechanisms, because the mechanisms are measurable and almost nobody writes them down. It is not permission to live on drive-through food, and it is not a diet plan. It is an explanation, plus the surprisingly large body of evidence about what a refined low residue diet does and does not do to Crohn's disease, including the randomised trial from 1985 that tested exactly the thing you are worried about and found nothing.

The short answer: you are comparing two different axes

The word "healthy" in everyday use bundles together nutrient density, low energy density, minimal processing and a general moral standing. None of those four things describes how hard a food is for a damaged or inflamed intestine to move and absorb.

Four things determine how a meal lands. We are listing the ones that have actually been measured, not ranking them, because no study has weighed them against each other in Crohn's disease:

  1. How much intact material reaches your intestine. Cooking, peeling, deseeding, milling, mincing and blending all reduce it. Raw, whole, skin-on and coarse all increase it.
  2. How much fermentable carbohydrate arrives in the colon. This is the FODMAP question, and it is concentrated in exactly the foods people call healthy: legumes, brassicas, onions, garlic, whole grains, stone fruit.
  3. How fast the whole thing moves. Fat slows it. Sugar and low viscosity liquid speed it up. Both directions can cause symptoms.
  4. The state of your gut on that particular day. Inflammation level, how full your bowel already was, sleep, stress, and the rest of what you ate.

A burger bun, a beef patty, fries and a shake score well on the first two and badly on nothing except nutrition. A chicken and quinoa salad with chickpeas and raw peppers is the inverse. The label swaps; the physiology does not care about the label.

This is the same observation as the "fast food paradox" section in our guide to what to eat during a Crohn's flare, which covers the residue-versus-fibre distinction and the practical flare food question. This article goes underneath it, into the measured mechanics.

What your stomach actually does to a salad

Before anything reaches your small intestine, your stomach has to reduce solid food to a gruel fine enough to pass the pylorus. That process is called trituration, and the gatekeeping is called gastric sieving: liquids and fine particles leave first while larger pieces are retained and ground down further.

The size threshold has been measured directly. In dogs with duodenal fistulas, normal fed-state stomach contractions retained pieces larger than about 0.5 mm for further reduction, and under control conditions only 7% of what reached the duodenum was in the larger-than-0.5 mm fraction. Give the same animals erythromycin, which forces powerful sweeping contractions, and 63% of the chyme arrived as large chunks essentially unchanged from what was swallowed (Lin 1994). That is canine work, not human, and the exact threshold in people is debated, but the principle transfers: your stomach is a mill with a size limit.

In humans the effect of doing the milling yourself has been imaged. In a two-part study, 22 volunteers ate roasted chicken and vegetables with a glass of water, or the identical meal blended to a soup, and rated their hunger; a separate group of 18 ate the same meals inside an MRI scanner. Blending abolished sieving, and gastric volume then fell more slowly rather than faster, with greater gallbladder contraction and a different pattern of small bowel water (Marciani 2012).

Two practical conclusions follow, and the second one surprises people:

  • Food that has already been processed skips a step your stomach would otherwise have to perform. Refined flour, mashed potato, a formed patty, a cooked-to-collapse vegetable: all of these are pre-triturated. A raw kale leaf, a whole nut, sweetcorn kernels, a piece of pepper skin and a strip of connective tissue in a steak are not.
  • Blending is not simply "easier". It reduces particle size, which helps passage, but in the MRI study it also delayed gastric emptying and increased the hormonal response to the meal. The fermentable material is still there. A dense smoothie can still produce a great deal of gas.

If vegetables come out looking like vegetables, that is not evidence of malabsorption. Humans have no enzyme for cellulose, so recognisable sweetcorn, pepper skin and lettuce in the toilet are normal. What Crohn's changes is how much discomfort that intact material causes on the way, particularly if it has to pass a narrowed segment.

The fermentable carbohydrate really is concentrated in the whole foods, and it has been weighed

The second mechanism is fermentation. Short-chain carbohydrates that your small intestine does not absorb reach your colon, where bacteria ferment them into gas and short-chain fatty acids. In a bowel that is already distended, inflamed or hypersensitive, that gas load is felt.

The useful thing here is that somebody actually measured the content of ordinary foods rather than assigning them a label. Fifty-five commonly eaten grains, cereals, breads, pulses and biscuits were analysed by high-performance liquid chromatography, with total fructan quantified enzymatically (Biesiekierski 2011). Total fructan per portion as eaten ran like this:

FoodTotal fructan per portion as eaten
Rice0 g
Potato chips (crisps)0.05 g
Spelt bread0.07 g
Oats0.11 g
Dark rye bread0.6 g
Muesli fruit bar0.81 g
Wheat-free muesli0.96 g
Couscous1.12 g

A portion of crisps carries roughly one twentieth of the fructan in a portion of couscous, and rice carries none that the assay could find. Raffinose and stachyose, the galacto-oligosaccharides, were most abundant in pulses, which is the measured version of why a bean chilli behaves differently from a bowl of white rice.

Three honest caveats, because this table gets misused. Fructans are one FODMAP among several, so a low-fructan food is not automatically a low-FODMAP food. The study analysed grain products, cereals, pulses and biscuits, not vegetables, so it does not tell you about broccoli. And FODMAP content is a property of the portion, not the food, which is why we treat low FODMAP in Crohn's as a short structured trial to be run with a dietitian, with a reintroduction phase, rather than as a permanent way to eat.

Does removing that fermentable load actually help in IBD? Partly, and the trial that tested it is worth reading carefully. Fifty-two people with quiescent Crohn's or ulcerative colitis and persistent gut symptoms were randomised to four weeks of a low FODMAP diet or a control diet. More reported adequate relief of gut symptoms on the low FODMAP arm, 14 of 27 (52%) versus 4 of 25 (16%), p = 0.007. But the trial's IBS severity score comparison, its primary symptom measure, was not statistically significant (p = 0.075), and the low FODMAP arm ended with significantly lower faecal abundance of Bifidobacterium adolescentis, Bifidobacterium longum and Faecalibacterium prausnitzii. Inflammatory markers did not differ (Cox 2020).

Why fibre can be the problem when your own microbes are not fermenting it

Here is the part that most patient-facing pages get wrong, because the population-level message about fibre is genuinely different from the individual one in active IBD.

Colonic biopsies from people with IBD were cultured and exposed to oligofructose, either intact or after 24 hours of anaerobic fermentation. Unfermented beta-fructan fibres induced proinflammatory cytokines in a subset of IBD biopsies and in immune cells, through NLRP3 and TLR2 activation. Fermenting the fibres first reduced that proinflammatory response, but only when the microbes doing the fermenting came from people without IBD or with inactive IBD. Fibre-induced immune responses correlated with microbe function, luminal metabolites, and, strikingly, with the patients' own reported fibre avoidance. The results were validated against an adult randomised trial of beta-fructan supplementation (Armstrong 2023).

The authors' own conclusion is careful and worth quoting in spirit: fibres are typically beneficial in people with normal fermentative potential, and some dietary fibres have detrimental effects in select patients with active IBD who lack that fermentative capacity.

That is a mechanism for "healthy food hurts me" that does not require you to be doing anything wrong. It also predicts the thing everyone notices, which is that it is inconsistent between people and inconsistent within one person over time, because fermentative capacity is not fixed. The grant list recorded for this study names public and charitable funders, including the Canadian Institutes of Health Research, NSERC, the Manitoba Medical Service Foundation and the Garfield Weston Foundation, and no company. We did not obtain the paper's own conflict of interest statement, so we are describing its funders rather than asserting an absence of conflicts.

Against that, the observational data point the other way, and both things are true. In 1,619 people from the Crohn's and Colitis Foundation of America Partners internet cohort who were in remission at baseline, those in the highest quartile of fibre intake were less likely to flare within six months than those in the lowest (adjusted OR 0.58, 95% CI 0.37 to 0.90), and people with Crohn's who said they did not avoid high-fibre foods were about 40% less likely to flare (adjusted OR 0.59, 95% CI 0.43 to 0.81). There was no association in ulcerative colitis, and the point estimate there ran in the opposite direction (adjusted OR 1.82, 95% CI 0.92 to 3.60) (Brotherton 2016).

Read the same paper's other finding before you act on that, though: participants with longer disease duration, previous surgery and previous IBD hospitalisation ate less fibre. That is the confounding in plain sight. People whose disease has been worse for longer avoid fibre, and people who avoid fibre flare more, and an observational study cannot tell you which way the arrow runs. The authors still concluded that recommendations to limit dietary fibre should be re-evaluated, which is a strong conclusion for a design that cannot establish direction.

Fat: why fried food settles some people and floors others

Fat is a third, separate mechanism, and it is not about residue at all.

When fat reaches the ileum, it triggers a reflex that slows everything upstream. Perfusing the human ileum with a fat-containing solution at concentrations resembling steatorrhoea raised mean transit time through a jejunal segment from 7.5 minutes to 18.9 minutes, increased segmental volume, and cut jejunal pressure wave activity from around 40% of the time to about 15%, with rises in enteroglucagon and neurotensin (Spiller 1984). Follow-up work showed the effect is specific to lipid: oleic acid, triolein and medium chain triglycerides all inhibited jejunal motility, while glycerol, protein and carbohydrate hydrolysates did not, and only the peptide YY rise correlated with the inhibition (Spiller 1988). In dogs, fat in the distal gut inhibited transit more potently than the same load in the proximal gut, in a load-dependent way (Lin 1997).

So when somebody says a greasy meal "coats the stomach" and calms things down, the feeling is real and the mechanism named is wrong. Nothing is being coated. Fat is pulling the emergency brake on transit, and slower transit can genuinely mean fewer, less urgent, better-formed stools for a few hours.

The same reflex explains why fat is the single most polarising variable in these threads. In the same discussion where most people said fast food was easier, one of the most upvoted replies was from somebody for whom anything deep fried meant pain for days (r/CrohnsDisease thread). Both experiences fit. Delayed emptying and slowed transit reduce urgency, and they also produce fullness, bloating and nausea. Which of those you notice depends on where your disease is and what your motility was doing already. Our guide to nausea after eating with Crohn's goes into the delayed-emptying side of this in detail.

There is one group for whom fat is reliably harder, and it is worth naming because it is common and frequently missed. If you have ileal disease or have had an ileal resection, bile acid handling changes. One recent multi-cohort study describes bile acid malabsorption as complicating more than 30% of Crohn's disease in its background framing, and found the clearest response to treatment in patients with ileal resection and ileal or ileocolonic disease (Lu 2025). Measured biomarkers line up with that: median serum 7-alfa-hydroxy-4-cholesten-3-one was 85.7 ng/mL in IBD patients after surgery, compared with 3.7 ng/mL in healthy controls (Lyutakov 2021).

The snack-pack turkey problem

One of the sharpest observations in these threads is that processed turkey slices from a snack pack go down fine while roast turkey causes days of trouble. It sounds absurd. Mechanically it is not.

Roast meat contains intact muscle fibre and connective tissue that your stomach has to break down and that survives in recognisable strands. Emulsified, formed and comminuted deli meat has already been ground, mixed and heat-set, so the structure your stomach would have had to dismantle has been dismantled in a factory. The nutritional comparison favours the roast turkey on almost every measure worth having. The mechanical comparison does not.

The same logic explains a lot of the specific foods people name:

  • White bread over wholemeal: bran and germ removed, so less intact structure and, on the measured values above, a different fructan load.
  • Fries over roast potatoes with skin: skin removed, high water loss, soft interior.
  • Chicken nuggets over grilled chicken breast: comminuted and bound rather than whole muscle.
  • Fruit juice or tinned peaches over a raw apple: skin, cell wall and most of the physical bulk gone, though the sugars remain and can produce their own osmotic problem.
  • Well-cooked, peeled, deseeded courgette over raw pepper: same food group, different mechanics entirely.

Notice that the last item on that list is not junk food at all. That is the most useful thing in this section. What the processed food is doing for you is mostly texture and residue reduction, and texture and residue reduction are available in real food if you cook it hard enough, peel it, deseed it and keep the portion small. That is the route back that does not require a drive-through.

What actually changes how a meal lands

ChangeWhat it altersUsual direction
Cooking until softParticle size, cell wall integrityEasier
Peeling and deseedingInsoluble residueEasier
BlendingParticle size, gastric emptying rateMixed: passage easier, gas unchanged, emptying slower
Refining a grainResidue and fructan loadEasier, nutritionally poorer
Increasing portion sizeTotal fermentable load and bulkHarder
Adding a large fat loadTransit speed, gastric emptyingSlower, which some people feel as relief and others as nausea
Eating the same total in smaller, more frequent amountsPeak load on any one segmentUsually easier
Raw and whole versus cooked and cutEverything above at onceHarder
Alcohol or a large caffeine dose alongsideMotility, secretionUsually harder

None of that is a prescription. It is a list of the variables worth changing one at a time, which is the only way a food experiment tells you anything.

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.

Join the waitlist

Somebody actually randomised this, in 1985

The thing you are quietly worried about is whether eating a soft refined diet is making your Crohn's worse. That question was put to a randomised trial forty years ago, and the result is not what either camp expects.

Seventy people with non-stenosing Crohn's disease were randomly assigned to follow a low residue diet or a normal Italian diet, for a mean of 29 months. Compliance was good and clearly separated: the low residue group ate a mean of 8.1 portions of fibre-containing foods per week, the liberalised group 26.6 portions. There was no difference in outcome between the groups on symptoms, need for hospitalisation, need for surgery, new complications, nutritional status or postoperative recurrence (Levenstein 1985).

The authors framed the finding as a case for lifting restrictions, and that is the standard way it is cited: a more appetising and more nutritious diet did not cause deterioration or precipitate obstruction. But the same abstract contains a second number that almost nobody quotes, and it is the one that speaks to this article. Eighty-six per cent of patients eating ad libitum, and 65% of those avoiding roughage, eliminated one or more permitted foods because of subjective intolerance.

In other words: in a trial specifically designed to test whether restriction was necessary, most participants in both arms restricted anyway, on their own initiative, because individual foods hurt. The trial found no benefit from the prescribed low residue rule and simultaneously documented that intolerance of specific foods was near-universal. Both halves of that are relevant to you.

Two limits on how far to carry this. The trial enrolled only non-stenosing disease, so it says nothing about strictures. And it predates faecal calprotectin, biologics and endoscopic endpoints entirely, so "no difference in outcome" means no difference in clinical outcome as measured in 1985.

Strictures change this question completely

If you have a narrowing, texture stops being about comfort and becomes about obstruction risk, and this is the one place where the food list genuinely matters.

The evidence base here is thin and honest about being thin. A narrative review of oral diet and nutrition support in stricturing and fistulising Crohn's found that dietary modification and exclusive enteral nutrition are both common practice while supporting research evidence is generally limited, with the strongest evidence being for enteral nutrition reducing surgical complications before an operation (Fansiwala 2023). Where a specific practice has been examined, it has not held up: adding a 24-hour liquid diet every 10 to 14 days to medical therapy in patients with small bowel strictures made no significant difference to new sub-occlusive episodes (10 of 37, 27%, versus 9 of 45, 20%) or to resection rates over 12 months, in a retrospective comparison (Marafini 2020).

The current AGA clinical practice update handles this by holding both ideas at once: everyone with IBD should be advised to follow a Mediterranean diet rich in fresh fruit and vegetables, monounsaturated fats, complex carbohydrates and lean proteins and low in ultraprocessed food, unless there is a contraindication, and that advice may require accommodations for food texture where there are strictures or obstruction (Hashash 2024). It is an expert review rather than a systematic review, and it says so: no formal rating of evidence quality was performed.

If you have stricturing disease, the relevant list is not about ultra-processed versus whole food but about particle size and passage, which we cover in more detail in the context of foods that cause an ileostomy blockage.

So is the processed food harming me? What the prospective data actually show

This is the question underneath the guilt, and the answer requires separating two things that health writing habitually merges: the risk of developing IBD, and the behaviour of IBD you already have.

On developing it, the association is real. In the PURE cohort, 116,087 adults across 21 countries were followed for a median of 9.7 years, during which 467 developed IBD. Higher ultra-processed food intake was associated with higher risk: hazard ratio 1.82 (95% CI 1.22 to 2.72) for five or more servings a day and 1.67 (1.18 to 2.37) for one to four servings a day, compared with less than one serving a day, with a p for trend of 0.006. Intakes of white meat, red meat, dairy, starch, and fruit, vegetables and legumes were not associated with incident IBD (Narula 2021).

Two details deserve more attention than they get. The hazard ratios for one to four servings a day and for five or more overlap almost entirely, so above about one serving a day this dataset shows very little dose-response, despite the significant trend test. And only 90 of the 467 incident cases were Crohn's disease, so the Crohn's-specific estimate rests on a small number of events even though the paper reports consistency across both diseases. A 2026 meta-analysis of seven prospective cohorts and 1,534,155 participants pooled a Crohn's odds ratio of 1.985 (95% CI 1.230 to 3.204, p = 0.005), an overall IBD odds ratio of 1.495 (1.028 to 2.174, p = 0.035), and no significant association for ulcerative colitis (1.324, 0.893 to 1.962, p = 0.163) (Mendoza-Rodriguez 2026). We checked those three estimates against their confidence intervals and p-values and the arithmetic is internally consistent. It is worth noting that the review pooled prospective cohort results as odds ratios rather than hazard ratios, and that the median Newcastle-Ottawa quality score of the included studies was 7, range 6 to 8.

On flares in established disease, the picture is different, and it is the part you actually need. PREdiCCt recruited 2,629 people with IBD in self-reported remission across 47 UK centres, assessed baseline diet with a validated food frequency questionnaire, and followed them for a median of 4.1 years. Baseline faecal calprotectin was strongly associated with flare: at 250 micrograms per gram or above, adjusted hazard ratio 2.22 for patient-reported flare and 3.25 for objective flare. Higher total meat intake was associated with objective flares in ulcerative colitis (highest versus lowest quartile, adjusted HR 1.95, 95% CI 1.07 to 3.56). And there were no consistent associations for ultraprocessed foods, fibre or polyunsaturated fatty acids and flare (Constantine-Cooke 2026).

That is currently the best prospective evidence on the question "will eating like this make me flare", and the answer it gives is that your calprotectin predicted your flares and your ultra-processed food intake did not. The UC meat finding is one association among many nutrients tested, with a confidence interval whose lower bound is 1.07, so it is fragile and it is also not about Crohn's disease.

A separate randomised trial in Crohn's points the same way from a different angle. In the FACES trial, 214 adults in remission were assigned to eat at least two servings of red or processed meat a week or no more than one serving a month, for 49 weeks, with good separation between the arms (2 or more servings in 98.5% of observed weeks versus 18.8%). There were no significant differences in time to any relapse (p = 0.61) or to moderate or severe relapse (p = 0.50) (Albenberg 2019).

There is also a study that quietly demonstrates how leaky the ultra-processed category is in this population. A pilot case-control study matched 47 children with IBD to healthy controls and scored intake with the NOVA system. Children with ulcerative colitis ate more ultra-processed food than controls (mean difference 10.5%, p = 0.02), there was no difference in children with Crohn's after excluding oral nutritional support, and ultra-processed intake did not differ between active and inactive disease (Kasznar 2025). Two days of 24-hour recall in 47 children is a small instrument, and the authors call it a pilot. But note what they had to do to make the analysis work: exclude the therapeutic formula from the ultra-processed tally.

The paradox nobody wants to say out loud

The single best-evidenced dietary therapy in Crohn's disease is an industrially manufactured liquid.

In a 12-week trial in 74 children with mild to moderate Crohn's, the Crohn's disease exclusion diet plus 50% of calories from formula was compared with exclusive enteral nutrition. The primary endpoint was dietary tolerance, and the combination diet won it: tolerated by 97.5% versus 73.6% (p = 0.002). Corticosteroid-free remission at week 6 was 30 of 40 (75%) versus 20 of 34 (59%), which was not statistically significant (p = 0.38). At week 12 it was 28 of 37 (75.6%) versus 14 of 31 (45.1%), which was significant (p = 0.01, odds ratio 3.77, CI 1.34 to 10.59), with sustained falls in CRP and faecal calprotectin in the combination arm (Levine 2019).

Read the denominators in that sequence: 40 and 38 at randomisation, 40 and 34 at week 6, 37 and 31 at week 12. The arm that was harder to tolerate lost more participants, which is the trial's own primary finding, and that attrition sits underneath the week-12 remission gap. The trial was funded in part by Nestlé Health Science, whose Modulen formula was the product used, and also by Janssen Biotech and GlaxoSmithKline Australia, alongside charitable and public funders.

Hold that next to the advice that people with Crohn's should minimise ultra-processed food. Exclusive enteral nutrition is a formula. The formula in the trial above is a formula. NOVA would not classify either as a whole food, which is precisely why the paediatric study above had to strip oral nutritional support out of its ultra-processed count before comparing Crohn's children with controls.

This does not mean the ultra-processed category is useless. It means "processing" is not one thing, and a category that puts a therapeutic enteral formula in the same bin as a soft drink is not going to predict your symptoms. That is not a rhetorical point: it is the most likely explanation for why PREdiCCt found no ultra-processed signal for flares while PURE found one for incidence.

"Eat clean" has been tested too

The advice you are getting from relatives is a testable hypothesis, and it has been tested against a stricter alternative.

DINE-CD randomised 194 adults with Crohn's and mild to moderate symptoms, 191 of whom entered the efficacy analyses, to the Specific Carbohydrate Diet or a Mediterranean diet for 12 weeks, with prepared meals and snacks supplied for the first six. Symptomatic remission at week 6 was 46.5% on SCD and 43.5% on the Mediterranean diet (p = 0.77). Faecal calprotectin response was achieved in 8 of 23 (34.8%) versus 4 of 13 (30.8%) (p = 0.83). CRP response was achieved in 2 of 37 (5.4%) versus 1 of 28 (3.6%) (p = 0.68), which the authors summarise plainly as uncommon (Lewis 2021).

So the elaborate elimination diet was not superior to the conventionally healthy one, and neither of them moved inflammatory markers in most people. The authors' conclusion was that given the greater ease of following a Mediterranean diet and its other health benefits, it may be preferred for most patients. That is a reasonable recommendation about general health. It is not evidence that a Mediterranean pattern controls your Crohn's, and it should not be quoted at you as if it were.

The emulsifier question has the same shape, and it is currently unresolved in public. A double-blind randomised feeding trial gave 24 adults with symptomatic, sonographically active ileal Crohn's four weeks of a diet either high or low in emulsifiers, both modelled on Australian healthy eating guidelines, with adherence above 95%. Sonographic activity scores fell on both diets. Bowel wall thickness reduced by 34% on the high emulsifier diet and 15% on the low one. Clinical remission occurred in 9 of 12 on high emulsifier and 7 of 12 on low. There were no statistically significant differences between diets, and the authors concluded that recommendations to avoid emulsifiers in active Crohn's are not supported (Fitzpatrick 2025).

Against that sits the ADDapt trial, a 154-patient multi-centre randomised re-supplementation study from King's College London, presented at ECCO in February 2025, reporting that emulsifier restriction made symptom improvement about three times more likely. We could find no full peer-reviewed publication of it in Europe PMC as of this writing, which matters, because independent statisticians asked to comment at the time flagged that only about 65% of the control group completed against about 81% of the intervention group, that missing outcome data appear to have been counted as non-response, and that in the per-protocol analysis most of the reported outcomes, or by one statistician's reading all of them, were no longer statistically significant (Science Media Centre expert reaction, 2025). So the headline rests on an intention-to-treat analysis whose result may be driven by unequal dropout. That is a reason to wait for the full paper, not a reason to dismiss the trial.

Same meal, different day

Almost every long thread on this eventually converges on the same complaint: some days everything works and some days nothing does, and the same chicken pot pie that caused days of pain three years ago passed without incident last week.

That is not you failing to keep records properly. It reflects two real things.

First, the symptom is not always the inflammation. Across 27 studies and 3,169 people with IBD in remission, the pooled prevalence of symptoms meeting IBS criteria was 32.5% (95% CI 27.4 to 37.9). Where remission was defined endoscopically it was 23.5%, and histologically 25.8%, so roughly a quarter of people still have these symptoms when inflammation has been objectively excluded. Prevalence was higher in Crohn's than in ulcerative colitis (36.6% versus 28.7%), and both anxiety and depression scores were higher in those reporting the symptoms (Fairbrass 2020). An earlier meta-analysis of 13 studies found pooled prevalence of 39% overall, with an odds ratio of 4.89 versus controls (Halpin 2012).

Second, your inflammation level is itself the biggest variable, and it moves. That is exactly what PREdiCCt showed with baseline calprotectin, and it is why the answer to "is this food my trigger, or is my disease more active this month" is a stool test rather than a better diary. We cover the discordance between how you feel and what the markers say in high calprotectin with no symptoms, and the question of whether a bad patch is a flare at all in how to tell if you are in a Crohn's flare.

The practical consequence is that a single meal almost never proves anything. Reactions in Crohn's also arrive late: hours after the meal, once material reaches the inflamed or fermenting part of the gut, which is why blaming the last thing you ate is usually wrong. Clairop tests every food you log against three delay windows rather than one, within six hours, six to twenty-four hours and one to three days, precisely because the meal that caused the trouble is often not the one that preceded it. You can see how that works on how it works.

The nutrition bill, and what it actually costs

If the inflammatory risk of a refined diet is not the real problem, the nutritional risk is.

Micronutrient deficiencies in IBD are common and under-tested. In a retrospective review of 611 patients hospitalised for an IBD flare, testing rates were low: copper in 12.3%, vitamin A in 10.1%, vitamin E in 10.3% and vitamin K in just 4.6%. Among those tested, deficiency rates were high: in Crohn's disease, 25.4% for copper, 53.3% for vitamin A, 23.7% for vitamin E and 29.4% for vitamin K (Kamel 2024).

Be careful reading that paper, because its denominators shift. The abstract also says "overall, 10.1% of patients had micronutrient deficiencies", which cannot be reconciled with a 53.3% vitamin A deficiency rate unless the two figures use different denominators, the whole cohort in one case and the tested subset in the other. It is also worth noting that 10.1% is the same figure the abstract gives for the vitamin A testing rate. We cannot tell from the abstract which reading is intended, so we are quoting the per-nutrient rates with their denominator stated and not the overall figure.

The starkest illustration of where a very narrow refined diet can end up is a 1997 French case report of scurvy in a person with Crohn's disease following a residue-free diet (Vasseur 1997). It is a case report in a letter, so it is a single event and proves nothing about frequency. It is included because it names the failure mode: the vitamins that are absent from a refined low residue diet are the ones that come from the foods it excludes.

This is where the guidelines are actually useful, and what they say is more permissive than the internet suggests. The ESPEN guideline on clinical nutrition in IBD states that routine provision of a special diet in IBD is not supported and that exclusion diets are generally not recommended, while strongly recommending treatment of iron deficiency, including parenterally if needed (Bischoff 2022); the 2023 update extends this to 71 graded recommendations (Bischoff 2023). The IOIBD dietary guidance is explicitly framed as expert opinion on which components it may be prudent to increase or decrease, precisely because the underlying evidence varies in quality (Levine 2020). There is also a European consensus on the dietary management of IBD (Svolos 2025); we could not obtain its abstract or full text through PubMed, Europe PMC or the publisher, so we cite it only for existing and make no claim about what it recommends.

What all of that adds up to, practically: nobody credible is going to tell you to eat the painful food. They are going to tell you to get the missing nutrients another way, which usually means a dietitian, sometimes means supplements, and always means having them measured rather than guessed. If weight rather than variety is the sticking point, the mechanics of adding energy inside a small safe-food list are covered in how to gain weight with Crohn's disease, which also explains why the scale is a poor instrument for this.

When restriction stops being a strategy

There is a point at which a sensible short-term narrowing becomes the problem itself, and it is worth knowing the signs.

A systematic review of seven studies found reported prevalence of avoidant/restrictive food intake behaviours in adults with IBD ranging from 10.2% to 51.3%, depending on the screening tool and cut-off, with a weighted mean of 24.2% at a NIAS cut-off of 24 or above and 18.6% at 28 or above. Higher levels were consistently linked to symptom-based disease activity, and, importantly, restrictive eating persisted in some patients whose inflammatory markers had normalised, suggesting mechanisms beyond inflammation. Gastrointestinal-specific anxiety was strongly associated (Caruso 2026). Two figures in that abstract are printed with decimal commas, as "24, 2%" and "18, 6%", which we have read as 24.2% and 18.6%.

One cross-sectional study of 239 patients in remission reports associations running the other way, with higher food-related quality of life and lower gastrointestinal-specific anxiety linked to the high-risk restrictive-eating group (Tian 2026). We cannot explain that from the abstract, and it contradicts the rest of the literature on this point, so we are flagging it rather than averaging it into a conclusion.

The psychosocial cost is measurable and it is not small. A systematic review of food-related quality of life in IBD identified disease activity, severe symptoms, previous IBD surgery, negative emotional reaction and restrictive eating behaviour as the main influences on it (Zhu 2025). In a survey of 137 people with older-onset IBD, 32% believed diet was the initiating factor for their disease, 43% believed diet could trigger relapse, and 68% avoided dietary components in order to avoid relapse. Twenty-nine per cent avoided eating out and 32% avoided eating the same meal as their family. Respondents rarely relied on healthcare professionals or patient organisations for their dietary information (Crooks 2021).

That last finding is the quiet one. People are making high-stakes dietary decisions from sources that are not their clinicians. The survey does not say why, though the size of the evidence gaps described throughout this article is a plausible part of it. If restriction has narrowed to a handful of foods, if you are avoiding family meals, or if eating has become something you dread rather than something you plan around, that is a reason to ask for a dietitian and possibly psychological support, not a reason to try harder alone. Our guide to whether the low FODMAP diet can cause an eating disorder goes into the screening question in more depth.

A worked example: four weeks and one honest question

Suppose the working theory is "vegetables hurt me". That statement is untestable, because it bundles at least five variables. Here is what testing one of them looks like.

Week 1, baseline. Change nothing. Log every meal, and log symptoms with timing rather than just a daily score. Note stool form, urgency, pain, bloating and how many hours after eating anything happened. The point of this week is to find out what your normal variability looks like, because without that you will attribute noise to food.

Week 2, texture only. Keep the same vegetables, in the same quantities, at the same meals. Change only the preparation: peeled, deseeded, cooked until it collapses, cut small. If the problem was residue and particle size, this is the week that improves, and it improves without you losing a food group.

Week 3, portion only. Go back to the week 1 preparation, but halve the portion of the suspect vegetable and keep everything else identical. If the problem was fermentable load rather than texture, this is the week that improves, and it tells you that you have a threshold rather than an allergy.

Week 4, the honest comparison. Reintroduce the original version once, deliberately, on a day when you are otherwise stable, and watch a full 72 hours. Reactions in Crohn's commonly arrive 6 to 24 hours later and sometimes 1 to 3 days later, so a clean 3-hour window means very little.

Then the piece most people skip. Take that to your IBD team with a stool calprotectin from the same period, because if inflammation rose across those four weeks then the food comparison is measuring the wrong thing. That is the single most useful thing you can bring: not a list of suspect foods, but the pairing of a food and symptom pattern with an objective marker from the same window.

Two warnings on this protocol. It only works if you change one variable at a time, and it does not apply if you have a known stricture, in which case texture decisions belong with your team rather than with a self-designed experiment.

How to answer people who tell you to just eat clean

This is the part of the question that has nothing to do with physiology and everything to do with being disbelieved. The most upvoted of the threads we read for this article is somebody at the end of their patience with unsolicited diet advice, and the replies are a catalogue of the same experience: a mother puzzled that something healthy could be bad for you, a stranger recommending hornet stings for joint pain, and the recurring compromise of describing exactly what happens after eating the recommended food until the advice stops (r/CrohnsDisease thread).

You do not owe anybody a lecture. But if you want one sentence with evidence behind it: healthy food and digestible food are different properties, the most nutrient-dense foods put the most intact material through the bowel, and both a randomised trial and a 2,629-person prospective cohort failed to find the dietary effect people assume exists.

A few things that help more than arguing:

  • Name the constraint, not the preference. "I can't digest that" lands differently from "I don't eat that". Several people in these threads described the shift from the second phrasing to the first as the thing that ended the conversations.
  • Redirect to the actual question. If someone wants to help, the useful help is a lift to an appointment or cooking something soft, not a list.
  • Do not take on the guilt of the food's reputation. A refined diet during a bad patch is a mechanical decision, not a moral failure, and the trial evidence does not support the idea that it is driving your disease.
  • Decide in advance who gets details. Several people in these threads settled on "I have dietary restrictions" as the full answer for colleagues and acquaintances.

If the disbelief is coming from a clinician rather than a relative, that is a different and more serious problem, and it is worth reading our guide to how to get your doctor to take gut symptoms seriously even though it is written for IBS.

Myths worth retiring

"Greasy food coats your stomach and protects it." Nothing is being coated. Fat delivered to the ileum triggers a reflex that slows jejunal motility and lengthens transit, measurably and reproducibly in humans (Spiller 1984, Spiller 1988). Slower transit can feel like relief. It can also feel like nausea and fullness, which is why the same meal helps one person and wrecks another.

"If processed food feels better, my Crohn's must be worse than I think." It is at least as likely to mean the opposite of what you fear. About a quarter of people with endoscopically confirmed remission still report IBS-type symptoms (Fairbrass 2020), so food intolerance and active inflammation are separate questions that need separate tests.

"Blending makes food easier, so blend everything." Blending reduces particle size, which usually helps passage, but in human MRI work it delayed gastric emptying rather than accelerating it and increased the hormonal response to the meal (Marciani 2012). The fermentable carbohydrate is untouched.

"Fibre is always good for you, including now." For most people, most of the time, yes. But unfermented beta-fructan fibres induced proinflammatory cytokines in biopsies from a subset of people with active IBD who lacked the microbes to ferment them, and pre-fermenting the fibre only helped when the microbes came from someone without active disease (Armstrong 2023).

"Cutting out ultra-processed food will stop my flares." Not on the current evidence for established disease. In 2,629 people with IBD followed a median of 4.1 years, ultra-processed food intake showed no consistent association with flare, while baseline calprotectin predicted it strongly (Constantine-Cooke 2026). The association with developing IBD in the first place is a different and better-supported claim (Narula 2021).

"Food additives are clearly the problem." The best published randomised feeding trial in active Crohn's found no difference in disease activity between high and low emulsifier diets over four weeks, with bowel wall thickness falling more on the high emulsifier arm (Fitzpatrick 2025). A larger trial reported the opposite at a conference, but has not been published in full, and its result may depend on how unequal dropout was handled.

"A stricter, cleaner diet will do more than a normal healthy one." Tested directly. The Specific Carbohydrate Diet was not superior to a Mediterranean diet for symptomatic remission, calprotectin response or CRP response in 191 adults with Crohn's (Lewis 2021).

"I should never have adopted a low residue diet." A low residue diet was randomised against a normal diet for a mean of 29 months in Crohn's and changed nothing either way (Levenstein 1985). On the evidence we could find, its cost is nutritional rather than inflammatory, and that cost is manageable with help.

"Sugar makes my joints hurt, so sugar is inflaming me." Several people describe joint pain after sweets, and we could find no evidence linking dietary sugar to joint symptoms in Crohn's. Joint pain in IBD has better-established explanations, covered in joint pain with Crohn's disease. Raise a pattern like that with your team rather than acting on the theory.

When to see a doctor promptly

Food tolerance changing is normal. Some things are not, and a refined diet can mask them by reducing symptoms without changing what is underneath. Contact your IBD team or GP promptly if you have:

  • New or increasing blood in your stool
  • Unexplained or continuing weight loss, or weight that keeps falling despite eating as much as you can manage
  • Symptoms that wake you at night
  • A fever, or night sweats, alongside gut symptoms
  • New or worsening abdominal pain, particularly pain that comes in waves after eating
  • Unusual tiredness or breathlessness, which can indicate anaemia
  • A food list that has narrowed to a handful of items, or difficulty maintaining weight on what you can tolerate
  • Diarrhoea that is worse after fatty meals, especially if you have ileal disease or an ileal resection, because bile acid malabsorption is treatable and commonly missed

Seek urgent, same-day help if you cannot keep fluids down, have severe abdominal pain with a tender or swollen abdomen, or have stopped passing stool and wind with pain and vomiting. Obstruction is a particular risk with stricturing Crohn's disease, and it is not something to manage at home by switching to softer food.

And ask specifically for a dietitian referral if your safe-food list is narrow. That is a legitimate clinical need rather than a nicety, and both the ESPEN guideline and the AGA update treat dietitian involvement as part of standard IBD care (Bischoff 2023, Hashash 2024).

The honest bottom line

Junk food feels better because "healthy" and "digestible" are different measurements, and processed food happens to score well on the one your gut cares about. Refining, cooking, milling and emulsifying reduce the mechanical work your stomach has to do and the fermentable substrate your bacteria receive. Those are the two properties that determine whether a meal is comfortable. Nutrient density is a third property, and it runs in the opposite direction.

The evidence on whether this is harming you is more reassuring than the advice you have been given. A randomised trial of a low residue diet in Crohn's found no effect on any outcome over more than two years. The largest prospective flare study in IBD found no consistent link between ultra-processed food and flares while finding a strong one for baseline calprotectin. A randomised trial of red and processed meat restriction in Crohn's remission found no effect on relapse. And the most effective dietary therapy in the condition is a manufactured formula, which should end the argument that processing alone is the villain.

What is genuinely at risk is your nutrition and your relationship with eating, and both of those are fixable with the right help rather than with willpower. The route back to variety runs through texture and portion, not through forcing down the version that hurts: cooked instead of raw, peeled instead of skin-on, small instead of large, one change at a time, with an inflammation marker alongside so you know what you are actually measuring.

One last thing worth saying plainly. We could find no trial that has ever tested the central question of this article, whether processed food is better tolerated than whole food in Crohn's disease. Everything above is mechanism plus adjacent evidence plus a large amount of consistent lived report. That is an honest account of what is known, and it is considerably more than the pages telling you to just eat clean have to offer. For more on eating, weight and appointments, browse our Crohn's disease guides.

Frequently asked questions

Why does junk food feel better than healthy food with Crohn's disease?
Because healthy and easy to digest are different properties, and processed food tends to score well on the second one. Refined, soft, low residue food arrives in the small bowel already broken down, carries very little fermentable carbohydrate, and leaves almost nothing intact to reach an inflamed or narrowed segment. Salad, brassicas, legumes, nuts and whole grains do the opposite on every one of those measures.
Is it the fibre, the fat, or the processing?
Often more than one of them, and they act by different routes. Cooking, peeling, milling and refining reduce how much intact plant material reaches your colon and how much substrate your bacteria have to ferment, which is the particle size and fermentation route. Fat does something separate: it slows transit rather than reducing bulk, which is why fried food settles some people and floors others. No study has ranked these against each other in Crohn's.
Am I damaging my gut by eating mostly processed food?
The evidence does not show that in established Crohn's. The largest prospective flare study, following 2,629 people with IBD for a median of 4.1 years, found no consistent association between ultra-processed food intake and flares, while baseline faecal calprotectin predicted them strongly. The real risk of a narrow refined diet is nutritional rather than inflammatory, which is a reason to involve a dietitian rather than to force feed yourself salad.
Does it mean my Crohn's is active if vegetables hurt?
Not necessarily. Around a third of people with IBD who are in remission still report symptoms that meet criteria for irritable bowel syndrome, and roughly a quarter do even when remission is confirmed endoscopically. Food intolerance can persist after inflammation is controlled. The way to separate the two is an inflammation marker such as faecal calprotectin, not a food diary, so ask your IBD team.
Has anyone actually tested a low residue diet in Crohn's disease?
Yes. In 1985, 70 people with non-stenosing Crohn's disease were randomly assigned to a low residue diet or a normal Italian diet for a mean of 29 months. There was no difference in symptoms, hospitalisation, surgery, new complications, nutritional status or postoperative recurrence. Notably, most people in both arms still dropped individual permitted foods because of their own intolerance.
Why do vegetables come out looking undigested?
Because insoluble plant structure is not meant to be digested by you. Human enzymes cannot break down cellulose, so recognisable pieces of sweetcorn, pepper skin or lettuce in the toilet are normal rather than a sign of malabsorption. What varies with Crohn's is how much discomfort those pieces cause on the way through, especially past a narrowed segment.
Should I just keep eating what works and stop trying vegetables?
That is a reasonable short-term strategy and a poor long-term one, and the middle path is texture rather than abstinence. Cooked, peeled, deseeded and blended versions of the same vegetable behave very differently from raw ones. Guidelines recommend a Mediterranean style pattern with accommodations for texture where there are strictures, and they recommend working that out with a dietitian rather than alone.
Why does the same meal hurt one week and not the next?
Because the variable is usually your gut, not the meal. Inflammation level, transit speed, how full your bowel already was, sleep, stress and the rest of what you ate that day all change how identical food lands. This is exactly why single-meal attribution produces false triggers and why patterns across many meals are more informative than the last thing you ate.
Is fast food actually recommended during a flare?
No, and no study has tested it. The honest position is that many people find refined, soft, low residue food easier during a bad patch, which is a mechanical observation rather than a recommendation, and that no guideline endorses fast food. There is also a real subgroup who find fried food makes things clearly worse.
How do I answer people who tell me to just eat clean?
You do not owe anyone a physiology lecture, but one line usually ends it: healthy food and digestible food are not the same thing, and the foods richest in nutrients are the ones that put the most intact material through an inflamed bowel. If you want evidence behind the line, a 1985 randomised trial and a 2,629-person prospective cohort both failed to find the dietary effect people assume exists.

Sources

  1. Levenstein S, Prantera C, Luzi C, D'Ubaldi A. Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut. 1985;26(10):989-93. doi:10.1136/gut.26.10.989
  2. Lin HC, Sanders SL, Gu YG, Doty JE. Erythromycin accelerates solid emptying at the expense of gastric sieving. Dig Dis Sci. 1994;39(1):124-8. doi:10.1007/BF02090071
  3. Marciani L, Hall N, Pritchard SE, Cox EF, Totman JJ, Lad M, et al. Preventing gastric sieving by blending a solid/water meal enhances satiation in healthy humans. J Nutr. 2012;142(7):1253-8. doi:10.3945/jn.112.159830
  4. Biesiekierski JR, Rosella O, Rose R, Liels K, Barrett JS, Shepherd SJ, et al. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet. 2011;24(2):154-76. doi:10.1111/j.1365-277X.2010.01139.x
  5. Armstrong HK, Bording-Jorgensen M, Santer DM, Zhang Z, Valcheva R, Rieger AM, et al. Unfermented beta-fructan fibers fuel inflammation in select inflammatory bowel disease patients. Gastroenterology. 2023;164(2):228-40. doi:10.1053/j.gastro.2022.09.034
  6. Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee YC, et al. The ileal brake: inhibition of jejunal motility after ileal fat perfusion in man. Gut. 1984;25(4):365-74. doi:10.1136/gut.25.4.365
  7. Spiller RC, Trotman IF, Adrian TE, Bloom SR, Misiewicz JJ, Silk DB. Further characterisation of the 'ileal brake' reflex in man: effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut. 1988;29(8):1042-51. doi:10.1136/gut.29.8.1042
  8. Lin HC, Zhao XT, Wang L. Intestinal transit is more potently inhibited by fat in the distal (ileal brake) than in the proximal (jejunal brake) gut. Dig Dis Sci. 1997;42(1):19-25. doi:10.1023/A:1018816517404
  9. Lu G, Zhang S, Wang R, Wu X, Chen Y, Wen Q, et al. Fecal microbiota transplantation improves bile acid malabsorption in patients with inflammatory bowel disease: results of microbiota and metabolites from two cohort studies. BMC Med. 2025;23(1):511. doi:10.1186/s12916-025-04353-y
  10. Lyutakov I, Lozanov V, Sugareva P, Valkov H, Penchev P. Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2021;33(3):380-7. doi:10.1097/MEG.0000000000001925
  11. Shiha MG, Ashgar Z, Fraser EM, Kurien M, Aziz I. High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria. EClinicalMedicine. 2020;25:100465. doi:10.1016/j.eclinm.2020.100465
  12. Fansiwala K, Shah ND, McNulty KA, Kwaan MR, Limketkai BN. Use of oral diet and nutrition support in management of stricturing and fistulizing Crohn's disease. Nutr Clin Pract. 2023;38(6):1282-95. doi:10.1002/ncp.11068
  13. Marafini I, Salvatori S, Troncone E, Scarozza P, Fantini E, Monteleone G. No effect of a liquid diet in the management of patients with stricturing Crohn's disease. Int J Colorectal Dis. 2020;35(10):1881-5. doi:10.1007/s00384-020-03650-7
  14. Hashash JG, Elkins J, Lewis JD, Binion DG. AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review. Gastroenterology. 2024;166(3):521-32. doi:10.1053/j.gastro.2023.11.303
  15. Narula N, Wong ECL, Dehghan M, Mente A, Rangarajan S, Lanas F, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021;374:n1554. doi:10.1136/bmj.n1554
  16. Mendoza-Rodriguez R, Gutierrez-Garrido A, Jimenez-Rosales R, Valverde-Lopez F, Fernandez-Garcia R, Redondo-Cerezo E. Ultra-processed food intake and risk of inflammatory bowel disease in the adult population: a systematic review and meta-analysis. Rev Esp Enferm Dig. 2026. doi:10.17235/reed.2026.11935/2026
  17. Constantine-Cooke N, Gros B, Plevris N, Williams LJ, Jones GR, Kyle J, et al. Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn's and Colitis (PREdiCCt) prospective cohort study. Gut. 2026;75(8):1491-504. doi:10.1136/gutjnl-2025-337846
  18. Kasznar E, Bajzat D, Karoliny A, Szentannay J, Szabo A, Gombos E, et al. Ultra-processed food intake in children with inflammatory bowel disease: a pilot case-control study. Nutrients. 2025;17(22):3532. doi:10.3390/nu17223532
  19. Chassaing B, Compher C, Bonhomme B, Liu Q, Tian Y, Walters W, et al. Randomized controlled-feeding study of dietary emulsifier carboxymethylcellulose reveals detrimental impacts on the gut microbiota and metabolome. Gastroenterology. 2022;162(3):743-56. doi:10.1053/j.gastro.2021.11.006
  20. Fitzpatrick JA, Gibson PR, Taylor KM, Anderson EJ, Friedman AB, Ardalan ZS, et al. Clinical trial: the effects of emulsifiers in the food supply on disease activity in Crohn's disease: an exploratory double-blinded randomised feeding trial. Aliment Pharmacol Ther. 2025;61(8):1276-89. doi:10.1111/apt.70041
  21. Levine A, Wine E, Assa A, Sigall Boneh R, Shaoul R, Kori M, et al. Crohn's disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology. 2019;157(2):440-50.e8. doi:10.1053/j.gastro.2019.04.021
  22. Lewis JD, Sandler RS, Brotherton C, Brensinger C, Li H, Kappelman MD, et al. A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults with Crohn's disease. Gastroenterology. 2021;161(3):837-52.e9. doi:10.1053/j.gastro.2021.05.047
  23. Cox SR, Lindsay JO, Fromentin S, Stagg AJ, McCarthy NE, Galleron N, et al. Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology. 2020;158(1):176-88.e7. doi:10.1053/j.gastro.2019.09.024
  24. Brotherton CS, Martin CA, Long MD, Kappelman MD, Sandler RS. Avoidance of fiber is associated with greater risk of Crohn's disease flare in a 6-month period. Clin Gastroenterol Hepatol. 2016;14(8):1130-6. doi:10.1016/j.cgh.2015.12.029
  25. Albenberg L, Brensinger CM, Wu Q, Gilroy E, Kappelman MD, Sandler RS, et al. A diet low in red and processed meat does not reduce rate of Crohn's disease flares. Gastroenterology. 2019;157(1):128-36.e5. doi:10.1053/j.gastro.2019.03.015
  26. Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(12):1053-62. doi:10.1016/S2468-1253(20)30300-9
  27. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107(10):1474-82. doi:10.1038/ajg.2012.260
  28. Kamel AY, Johnson ZD, Hernandez I, Nguyen C, Rolfe M, Joseph T, et al. Micronutrient deficiencies in inflammatory bowel disease: an incidence analysis. Eur J Gastroenterol Hepatol. 2024;36(10):1186-92. doi:10.1097/MEG.0000000000002821
  29. Vasseur E, Delaunay J, Meyniel D, Cocheton JJ. [Scurvy after a residue-free diet in Crohn disease]. Presse Med. 1997;26(5):214. https://pubmed.ncbi.nlm.nih.gov/9122112/
  30. Bischoff SC, Bager P, Escher J, Forbes A, Hebuterne X, Hvas CL, et al. ESPEN guideline on clinical nutrition in inflammatory bowel disease. Clin Nutr. 2023;42(3):352-79. doi:10.1016/j.clnu.2022.12.004
  31. Bischoff SC, Escher J, Hebuterne X, Klek S, Krznaric Z, Schneider S, et al. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Nutr Hosp. 2022;39(3):678-703. doi:10.20960/nh.03857
  32. Levine A, Rhodes JM, Lindsay JO, Abreu MT, Kamm MA, Gibson PR, et al. Dietary guidance from the International Organization for the Study of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020;18(6):1381-92. doi:10.1016/j.cgh.2020.01.046
  33. Svolos V, Gordon H, Lomer MCE, Aloi M, Bancil A, Day AS, et al. European Crohn's and Colitis Organisation consensus on dietary management of inflammatory bowel disease. J Crohns Colitis. 2025;19(9):jjaf122. doi:10.1093/ecco-jcc/jjaf122
  34. Caruso A, Latella G, Di Giacomo D, Galli F. Prevalence and clinical correlates of avoidant/restrictive food intake disorder (ARFID) among patients with inflammatory bowel disease: a systematic review. J Clin Psychol Med Settings. 2026. doi:10.1007/s10880-026-10155-y
  35. Zhu W, Zhang Y, Wang LD, Li J, Hou S. Factors influencing food-related quality of life in patients with inflammatory bowel disease: a systematic review. J Eval Clin Pract. 2025;31(2):e14133. doi:10.1111/jep.14133
  36. Crooks B, Misra R, Arebi N, Kok K, Brookes MJ, McLaughlin J, et al. The dietary practices and beliefs of people living with older-onset inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2021;33(1S Suppl 1):e442-8. doi:10.1097/MEG.0000000000002130
  37. Tian Y, Gao B, Qiao J, Fei H, Wu Y, Xu M. Latent profile analysis of avoidant/restrictive food intake disorder in patients with inflammatory bowel disease in remission: a cross-sectional study. Medicine. 2026;105(26):e49494. doi:10.1097/MD.0000000000049494

Clairop is a general wellness app for people living with a diagnosed digestive condition. It does not replace professional medical care, diagnosis, or treatment. Always follow your healthcare provider's advice.

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.

Join the waitlist

Launching soon on iOS

Find out what your gut actually reacts to

Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later rather than minutes later.

One email when Clairop launches. No spam, and you can unsubscribe any time.